NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), today announced positive topline data from VESPER-1 and positive data from a planned interim analysis for tolerability of ...

Based on federal safety guidelines, we outline four important but easy steps to ensure the safe operation of your portable generator Pay close attention to safety guidelines when setting up a ...

Ajay has worked in tech journalism for over a decade as a reporter, analyst, product reviewer, and editor. He got his start in consumer tech, breaking Android news at Newsweek before going to PCMag, ...

A digital therapeutic (DTx) that aims to treat negative symptoms of schizophrenia, like apathy and social withdrawal, has hit the target in a phase 3 trial. The smartphone-based CT-155 app, ...

MoonLake Immunotherapeutics (MLTX) shares plunged after the company reported results from its Phase 3 trials for sonelokimab in hidradenitis suppurativa. The VELA-2 study missed its main goal, ...

Vir Biotechnology (VIR) “announced that the first patient has been dosed in Part 3 of the Company’s Phase 1 clinical trial evaluating VIR-5500 in combination with androgen receptor pathway inhibitors.

The MCU’s Phase 4 released instalments during 2021 and ’22, Phase 5 released during 2023, ’24, and ’25, and Phase 6 will run until 2027. Following this pattern, the MCU’s Phase 7 will likely span ...

The 36 teams have discovered their fate for the UEFA Europa League league phase.

NEW DELHI: A top executive of homegrown telecom gear maker HFCL said it has won deals in 40-45% gram panchayats (GPs) under the BharatNet Phase 3 programme, and has started supplying its network ...

The firm’s analysis was influenced by the progress of Moonlake’s Phase III VELA clinical trials for sonelokimab in treating hidradenitis suppurativa. The VELA-2 trial has completed its last patient ...

OpenAI has released Sora 2, a new video and audio generation model designed to compete with Google's Veo 3. Sora 2, currently available through the Sora app for iPhone, lets users create, remix, and ...